U.S. Continuous Renal Replacement Therapy Market Size, Share & Trends Analysis Report By Product (CRRT System, Disposables, Liquids), By Modality (SCUF, CVVH, CVVHD, CVVHDF), And Segment Forecasts, 2021 - 2028

Table of Contents

Chapter 1 Research Methodology
                 1.1 Research Methodology
                       1.1.1 Information Procurement
                 1.2 Information or Data Analysis
                 1.3 Market Formulation & Validation
                 1.4 U.S. Market: CAGR Calculation
                 1.5 U.S. Based Segment Share Calculation
                 1.6 Model Details
                       1.6.1 Commodity Flow Analysis (Model 1)
                       1.6.2 Volume Price Analysis (Model 2)
                 1.7 List of Secondary Sources
Chapter 2 Objectives
                 2.1 Objective - 1:
                 2.2 Objective - 2:
                 2.3 Objective - 3:
                 2.4 Objective - 4:
Chapter 3 Executive Summary
                 3.1 Market Outlook
                 3.2 Segment Outlook
                 3.3 Competitive Insights
                       3.3.1 Market Segmentation
                 3.4 Market Snapshot
Chapter 4 Continuous Renal Replacement Therapy Market Variables, Trends & Scope
                 4.1 Market Lineage Outlook
                       4.1.1 Parent Market outlook
                       4.1.2 Ancillary Market
                 4.2 Penetration & Growth Prospect Mapping
                 4.3 Regulatory Framework
                 4.4 Pipeline Analysis
                 4.5 Market Dynamics
                       4.5.1 Market Driver Analysis
                            4.5.1.1 Increasing prevalence of Acute Kidney Injury (AKI) and associated chronic kidney disease
                            4.5.1.2 Rising geriatric population
                            4.5.1.3 Technological advancements in CRRT machines
                            4.5.1.4 Presence of a large number of hospitals & dialysis clinics and increasing healthcare expenditure
                       4.5.2 Market Restraint Analysis
                            4.5.2.2 Complications associated with usage of CRRT in critically ill neonates
                       4.5.3 Market Opportunity Analysis
                            4.5.3.1 Advancements in CRRT data management
                       4.5.4 Market Challenge Analysis
                            4.5.4.1 Availability of alternative therapies
                 4.6 Continuous Renal Replacement Therapy Market Analysis Tools
                       4.6.1 SWOT Analysis, By PEST
                       4.6.2 Porter’s Five Forces Analysis
                 4.7 Major Deals & Strategic Alliances Analysis
                       4.7.1 Geographical Expansion
                       4.7.2 Product Launches
                 4.8 COVID-19 Market Impact
                       4.8.1 Supply Chain
                       4.8.2 Changing Market Trends
Chapter 5 Continuous Renal Replacement Therapy Market: Segment Analysis, By Product, 2016 - 2028 (USD Million)
                 5.1 Definitions & Scope
                 5.2 Product Market Share Analysis, 2020 & 2028
                 5.3 Continuous Renal Replacement Therapy Market, By Product, 2015 to 2028
                 5.4 Market Size Forecasts And Trend Analysis
                       5.4.1 CRRT System
                            5.4.1.1 CRRT System Market, 2015 - 2028 (USD Million)
                       5.4.2 Disposables
                            5.4.2.1 Disposables Market, 2015 - 2028 (USD Million)
                       5.4.3 Liquids
                            5.4.3.1 Liquids Market, 2015 - 2028 (USD Million)
Chapter 6 Continuous Renal Replacement Therapy Market: Segment Analysis, By Modality, 2016 - 2028 (USD Million)
                 6.1 Definitions & Scope
                 6.2 Modality Market Share Analysis, 2020 & 2028
                 6.3 Continuous Renal Replacement Therapy Market, By Modality, 2016 to 2028
                 6.4 Market Size Forecasts And Trend Analysis
                       6.4.1 Slow Continuous Ultrafiltration (SCUF)
                            6.4.1.1 Slow Continuous Ultrafiltration (SCUF) Market, 2016 - 2028 (USD Million)
                       6.4.2 Continuous Venovenous Hemofiltration (CVVH)
                            6.4.2.1 Continuous Venovenous Hemofiltration (CVVH) Market, 2016 - 2028 (USD Million)
                       6.4.3 Continuous Venovenous Hemodialysis (CVVHD)
                            6.4.3.1 Continuous Venovenous Hemodialysis (CVVHD) Market, 2016 - 2028 (USD Million)
                       6.4.4 Continuous Venovenous Hemodiafiltration (CVVHDF)
                            6.4.4.1 Continuous Venovenous Hemodiafiltration (CVVHDF) market, 2016 - 2028 (USD Million)
Chapter 7 Continuous Renal Replacement Therapy Market: Competitive Analysis
                 7.1 Company Profiles
                       7.1.1 Baxter
                            7.1.1.1 Company overview
                            7.1.1.2 Financial performance
                            7.1.1.3 Product benchmarking
                            7.1.1.4 Strategic initiatives
                       7.1.2 B. Braun Melsungen AG
                            7.1.2.1 Company overview
                            7.1.2.2 Financial performance
                            7.1.2.3 Product benchmarking
                            7.1.2.4 Strategic initiatives
                       7.1.3 Fresenius Medical Care AG
                            7.1.3.1 Company overview
                            7.1.3.2 Financial performance
                            7.1.3.3 Product benchmarking
                            7.1.3.4 Strategic initiatives
                       7.1.4 Medtronic
                            7.1.4.1 Company overview
                            7.1.4.2 Financial performance
                            7.1.4.3 Product benchmarking
                            7.1.4.4 Strategic initiatives
                       7.1.5 Asahi Kasei Medical Co., Ltd.
                            7.1.5.1 Company overview
                            7.1.5.2 Financial performance
                            7.1.5.3 Product benchmarking
                            7.1.5.4 Strategic initiatives
                       7.1.6 Nipro Corporation
                            7.1.6.1 Company overview
                            7.1.6.2 Financial performance
                            7.1.6.3 Product benchmarking
                            7.1.6.4 Strategic initiatives

List of Tables

Table 1. U.S. continuous renal replacement therapy market, by product, 2016 - 2028 (USD Million)
Table 2. U.S. continuous renal replacement therapy market, by modality, 2016 - 2028 (USD Million)

List of Figures

Fig. 1 Market research process
Fig. 2 Information procurement
Fig. 3 Primary research pattern
Fig. 4 Market research approaches
Fig. 5 Value chain based sizing & forecasting
Fig. 6 QFD modelling for market share assessment
Fig. 7 Market formulation & validation
Fig. 8 U.S. continuous renal replacement therapy market segmentation
Fig. 9 Market summary (2020)
Fig. 10 Market lineage outlook
Fig. 11 Penetration & growth prospect mapping
Fig. 12 Regulatory framework
Fig. 13 Market driver relevance analysis (current & future impact)
Fig. 14 Market restraint relevance analysis (current & future impact)
Fig. 15 U.S. continuous renal replacement therapy market SWOT analysis
Fig. 16 SWOT analysis, by factor (political & legal, economic and technological)
Fig. 17 Porter’s five forces analysis
Fig. 18 Continuous renal replacement therapy market: product movement analysis
Fig. 19 Continuous renal replacement therapy market product outlook: Key takeaways
Fig. 20 CRRT systems market, 2016 - 2028 (USD Million)
Fig. 21 Disposable’s market, 2016 - 2028 (USD Million)
Fig. 22 Liquid’s market, 2016 - 2028 (USD Million)
Fig. 23 Continuous renal replacement therapy market: modality movement analysis
Fig. 24 Continuous renal replacement therapy market modality outlook: Key takeaways
Fig. 25 Slow continuous ultra-filtration (SCUF) market, 2016 - 2028 (USD Million)
Fig. 26 Continuous venovenous hemofiltration (CVVH) market, 2016 - 2028 (USD Million)
Fig. 27 Continuous Venovenous Hemodialysis (CVVHD) market, 2016 - 2028 (USD Million)
Fig. 28 Continuous venovenous hemodiafiltration (CVVHDF) market, 2016 - 2028 (USD Million)